Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven N Hart

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2021
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumAnna Morra, Audrey Y Jung, Sabine Behrens, et al.
The Journal of Pathology|August 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJeppe Thagaard, Glenn Broeckx, David B Page, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications|May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
British Journal of Cancer|February 22, 2019
Genome-wide association study of germline variants and breast cancer-specific mortalityMaria Escala-Garcia, Qi Guo, Thilo Dörk, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2021
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumAnna Morra, Audrey Y Jung, Sabine Behrens, et al.
The Journal of Pathology|August 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJeppe Thagaard, Glenn Broeckx, David B Page, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Nature Communications|May 15, 2021
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
British Journal of Cancer|February 22, 2019
Genome-wide association study of germline variants and breast cancer-specific mortalityMaria Escala-Garcia, Qi Guo, Thilo Dörk, et al.
Pageof 13